UnitedHealth Group Incorporated $UNH Shares Sold by AGF Management Ltd.

AGF Management Ltd. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 80.1% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,938 shares of the healthcare conglomerate’s stock after selling 72,268 shares during the quarter. AGF Management Ltd.’s holdings in UnitedHealth Group were worth $5,596,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its holdings in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Fort Sheridan Advisors LLC grew its holdings in UnitedHealth Group by 18.5% in the first quarter. Fort Sheridan Advisors LLC now owns 699 shares of the healthcare conglomerate’s stock valued at $366,000 after purchasing an additional 109 shares during the period. Financial Security Advisor Inc. raised its stake in shares of UnitedHealth Group by 9.5% during the 1st quarter. Financial Security Advisor Inc. now owns 2,541 shares of the healthcare conglomerate’s stock worth $1,331,000 after buying an additional 221 shares during the period. Finally, TruNorth Capital Management LLC lifted its position in shares of UnitedHealth Group by 137.3% during the 1st quarter. TruNorth Capital Management LLC now owns 318 shares of the healthcare conglomerate’s stock valued at $167,000 after buying an additional 184 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.8%

Shares of UnitedHealth Group stock opened at $324.29 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The firm has a market capitalization of $293.75 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 2.28 and a beta of 0.47. The stock has a 50 day moving average of $345.84 and a 200 day moving average of $321.90.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the business posted $7.15 EPS. The company’s revenue was up 12.2% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Barclays upped their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Truist Financial lifted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. KeyCorp increased their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.